Alzamend Neuro is trading at $1.55, up +6.51%, with no fresh company-specific announcement identified for its November 4 move.
- The latest company news listed was from September.
- XBI was reported up 2.13% during the regular session. The broader market was also sharply higher, supporting a risk-on backdrop; neither factor establishes the precise cause of Alzamend Neuro’s move.